Investigating the Gliogenic Genes and Signaling Pathways in the Pathogenesis of Huntington’s Disease: A Systematic Review

Author:

Shafi Ovais1ORCID,Raveena 1,Yaqoob Uzair1,Haseeb Madiha1,Madhwani Manwar1,Virk Luqman Naseer1,Zaidi Syed Wajahat Ali1,Nadeem Ammar1

Affiliation:

1. Sindh Medical College - Jinnah Sindh Medical University / Dow University of Health Sciences, Karachi, Pakistan

Abstract

Abstract Background: The pathophysiology of Huntington's disease (HD), a neurodegenerative condition, is considered to also involve glial cells. Understanding the intricate interactions between neurons and glia can be accomplished by looking at gliogenic pathways and transcriptional dysregulation. Understanding glial involvement may result in novel medicines, biomarkers, and a thorough understanding of HD's molecular foundation, thereby altering patient outcomes and disease management. Methods: Databases including PubMed, MEDLINE and Google Scholar were searched for published articles without any date restrictions, involving Huntington’s disease, gliogenesis, gliogenic genes and signaling pathways, astrocytogenic genes. Results: This study reveals the complex interactions between gliogenic pathways and disease etiology. Key factors Pax6, Nkx6.1, Sox9, Sox4, and NFIX are impacted by transcriptional dysregulation, which may interfere with gliogenesis and cellular differentiation. TGF-beta, JAK-STAT, SHH, and NF-B dysregulated signaling pathways emphasize their part in astrocyte dysfunction and glial-neuronal interactions. GFAP, S100, and NF-B are implicated in neuroprotection and are also involved in HD pathogenesis. The intricate interplay of transcriptional factors and pathways complicates the mechanisms behind HD. Therapeutically, gliogenic pathway modulation, transcriptional balance restoration, and glial dysfunction targeting offer promising approaches to slow the course of HD. Even if there are still gaps, current research will improve our knowledge of gliogenic processes and of their possible implications in HD neurodegeneration. Conclusion: The investigation of gliogenic pathways and molecules in Huntington's disease (HD) reveals insights into potential glial dysfunction contributions. Alterations to signaling pathways (TGF-beta, JAK-STAT, SHH), astrocyte-related molecules (GFAP, S100, NF-B), and transcriptional dysregulation may all have an impact on how the disease develops. Complexity is added by transcription factors that affect cellular differentiation (HOPX, Sox9, Sox4, NFIX). The interaction between pathways emphasizes how complex HD pathogenesis is. Genetic and epigenetic alterations, stress reactions, and interactions between pathways all contribute to dysregulation. A growing understanding of gliogenesis and its possible implications in HD are provided in this study, opening up possibilities for therapeutic investigation and mitigating the effects of glial-driven HD.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3